Godiva-IV Dosimetry Exercise 2022 (IER-538 CED4A Report)
This report presents the final results of IER 538, The International Nuclear Accident Dosimeter (NAD) Intercomparison Exercise with Godiva-IV. The purpose of the exercise, held in August of 2022, was to test participants’ NADs and dosimetry personnel to the dose estimation requirements established by ANSI/HPS-N13.3 Dosimetry for Criticality Accidents and DOE-STD-1098-2017, Radiological Control. Two prompt critical bursts of the Godiva critical assembly were used to simulate criticality accidents, and NADs from participating laboratories were placed at known locations around Godiva, mounted on either BOttle Manikin ABsorptions (BOMABs) phantoms (to simulate doses received by people) or plates (to simulate doses in free air). Similar exercises have been held in 2016 and 2018 using National Criticality Experiments Research Center’s (NCERC’s) Flattop and Godiva assemblies.